Maywufa Co Ltd - Asset Resilience Ratio
Maywufa Co Ltd (1731) has an Asset Resilience Ratio of 12.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Maywufa Co Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Maywufa Co Ltd's Asset Resilience Ratio has changed over time. See Maywufa Co Ltd net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Maywufa Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 1731 stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$396.63 Million | 12.77% |
| Total Liquid Assets | NT$396.63 Million | 12.77% |
Asset Resilience Insights
- Moderate Liquidity: Maywufa Co Ltd has 12.77% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Maywufa Co Ltd Industry Peers by Asset Resilience Ratio
Compare Maywufa Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Yunnan Baiyao Group Co Ltd
SHE:000538 |
Drug Manufacturers - Specialty & Generic | 8.38% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
Haleon plc
NYSE:HLN |
Drug Manufacturers - Specialty & Generic | 4.06% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.62% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601 |
Drug Manufacturers - Specialty & Generic | 12.24% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
Annual Asset Resilience Ratio for Maywufa Co Ltd (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Maywufa Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 13.53% | NT$430.12 Million ≈ $13.55 Million |
NT$3.18 Billion ≈ $100.13 Million |
-0.42pp |
| 2023-12-31 | 13.95% | NT$395.13 Million ≈ $12.45 Million |
NT$2.83 Billion ≈ $89.23 Million |
-2.13pp |
| 2022-12-31 | 16.08% | NT$406.87 Million ≈ $12.82 Million |
NT$2.53 Billion ≈ $79.71 Million |
-7.75pp |
| 2021-12-31 | 23.83% | NT$641.66 Million ≈ $20.22 Million |
NT$2.69 Billion ≈ $84.83 Million |
+3.46pp |
| 2020-12-31 | 20.37% | NT$504.51 Million ≈ $15.89 Million |
NT$2.48 Billion ≈ $78.02 Million |
-0.16pp |
| 2019-12-31 | 20.54% | NT$561.76 Million ≈ $17.70 Million |
NT$2.74 Billion ≈ $86.17 Million |
+19.12pp |
| 2018-12-31 | 1.42% | NT$38.01 Million ≈ $1.20 Million |
NT$2.67 Billion ≈ $84.21 Million |
+0.48pp |
| 2017-12-31 | 0.94% | NT$25.00 Million ≈ $787.67K |
NT$2.65 Billion ≈ $83.50 Million |
-0.71pp |
| 2016-12-31 | 1.66% | NT$43.01 Million ≈ $1.35 Million |
NT$2.60 Billion ≈ $81.84 Million |
+0.44pp |
| 2015-12-31 | 1.22% | NT$32.00 Million ≈ $1.01 Million |
NT$2.63 Billion ≈ $82.86 Million |
-8.65pp |
| 2014-12-31 | 9.87% | NT$248.56 Million ≈ $7.83 Million |
NT$2.52 Billion ≈ $79.38 Million |
-4.86pp |
| 2013-12-31 | 14.73% | NT$377.46 Million ≈ $11.89 Million |
NT$2.56 Billion ≈ $80.74 Million |
+10.13pp |
| 2012-12-31 | 4.59% | NT$114.90 Million ≈ $3.62 Million |
NT$2.50 Billion ≈ $78.79 Million |
-7.51pp |
| 2011-12-31 | 12.10% | NT$297.44 Million ≈ $9.37 Million |
NT$2.46 Billion ≈ $77.43 Million |
-7.05pp |
| 2010-12-31 | 19.15% | NT$544.90 Million ≈ $17.17 Million |
NT$2.84 Billion ≈ $89.63 Million |
-2.56pp |
| 2009-12-31 | 21.72% | NT$613.20 Million ≈ $19.32 Million |
NT$2.82 Billion ≈ $88.96 Million |
+1.03pp |
| 2008-12-31 | 20.69% | NT$542.13 Million ≈ $17.08 Million |
NT$2.62 Billion ≈ $82.57 Million |
+13.53pp |
| 2007-12-31 | 7.16% | NT$225.82 Million ≈ $7.11 Million |
NT$3.15 Billion ≈ $99.39 Million |
+3.14pp |
| 2004-12-31 | 4.02% | NT$118.61 Million ≈ $3.74 Million |
NT$2.95 Billion ≈ $92.99 Million |
+0.11pp |
| 2003-12-31 | 3.91% | NT$95.59 Million ≈ $3.01 Million |
NT$2.45 Billion ≈ $77.05 Million |
+0.33pp |
| 2002-12-31 | 3.57% | NT$86.02 Million ≈ $2.71 Million |
NT$2.41 Billion ≈ $75.83 Million |
-- |
About Maywufa Co Ltd
Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. The company engages in the manufacturing, processing, and distribution of hairdressing products, soap, and cosmetics; distribution, wholesale, and retail trading of various beauty products, health products, and sports equipment; retail and wholesale business of health food, such as vitamin p… Read more